NCT05890794 - Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

July 7, 2023

Study Completion Date

July 12, 2023

Conditions

Hypophosphatasia

Interventions

BIOLOGICAL

Ilofotase Alfa, 0.8 mg/kg

Biological: single 1-hour intravenous infusion of 0.8 mg/kg ilofotase alfa

BIOLOGICAL

Ilofotase Alfa, 3.2 mg/kg

Biological: single 1-hour intravenous infusion of 3.2 mg/kg ilofotase alfa

Trial Locations (1)

Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KLH, Würzburg